Vopratelimab
Vopratelimab (JTX-2011) is a selective humanized immunoglobulin G1-kappa monoclonal antibody and a potent ICOS agonist with high affinity for inducible T cell co-stimulating factors (ICOS), showing affinities of 0.93 nM for hICOS, 3.7 nM for rat ICOS, and 0.64 nM for mICOS. It exhibits anti-tumor immune effects and can improve metastatic non-small cell lung cancer.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
2039148-04-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1155415-01 0.02 mg (E-Coli)
Recombinant Mycobacterium tuberculosis Uncharacterized protein Rv0814c (Rv0814c)
Ask
View Details MBS1155415-02 0.1 mg (E-Coli)
Recombinant Mycobacterium tuberculosis Uncharacterized protein Rv0814c (Rv0814c)
Ask
View Details 
MBS1155415-03 0.02 mg (Yeast)
Recombinant Mycobacterium tuberculosis Uncharacterized protein Rv0814c (Rv0814c)
Ask
View Details MBS1155415-04 0.1 mg (Yeast)
Recombinant Mycobacterium tuberculosis Uncharacterized protein Rv0814c (Rv0814c)
Ask
View Details MBS1155415-05 0.02 mg (Baculovirus)
Recombinant Mycobacterium tuberculosis Uncharacterized protein Rv0814c (Rv0814c)
Ask
View Details